VJHemOnc is committed to improving our service to you

SOHO 2020 | Updates from the German CLL Study Group

VJHemOnc is committed to improving our service to you

Michael Hallek

Michael Hallek, MD, University Hospital of Cologne, Cologne, Germany, updates us on the latest news from the German CLL Study Group including updates from CLL14 (NCT02242942) to be presented at ASH, as well as ongoing trials such as CLL17 (NCT03701282), investigating ibrutinib and obinutuzumab with or without venetoclax. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter